HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexandra Winkeler Selected Research

9-(4-fluoro-3-hydroxymethylbutyl)guanine

7/2007Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene.
2/2007Imaging-guided gene therapy of experimental gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexandra Winkeler Research Topics

Disease

17Neoplasms (Cancer)
06/2022 - 02/2007
17Glioma (Gliomas)
06/2022 - 02/2003
3Brain Neoplasms (Brain Tumor)
06/2022 - 07/2007
3Inflammation (Inflammations)
11/2017 - 02/2016
2Glioblastoma (Glioblastoma Multiforme)
06/2022 - 12/2020
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2017
2Neuroinflammatory Diseases
03/2017 - 05/2012
2Infections
06/2011 - 02/2003
1Amyloid Plaque
01/2022
1Stroke (Strokes)
01/2018
1Cancer Pain
11/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2017
1Brain Ischemia (Cerebral Ischemia)
03/2017
1Disease Progression
12/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2008
1Lung Neoplasms (Lung Cancer)
01/2008
1Tics (Tic)
07/2007
1Gliosarcoma
02/2003

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
06/2022 - 05/2012
7N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA
01/2021 - 05/2012
4Amino AcidsFDA Link
06/2022 - 01/2021
3Biomarkers (Surrogate Marker)IBA
10/2019 - 05/2012
3Green Fluorescent ProteinsIBA
06/2011 - 02/2003
2gamma-glutamylaminomethylsulfonic acid (GAMS)IBA
06/2022 - 01/2020
2acetamideIBA
01/2022 - 12/2013
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 01/2020
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2008
2ErbB Receptors (EGF Receptor)IBA
12/2020 - 01/2008
2Carbon-11IBA
01/2018 - 11/2017
2CannabinoidsIBA
11/2017 - 03/2017
2Ganciclovir (Cytovene)FDA LinkGeneric
11/2007 - 02/2003
2GuanineIBA
11/2007 - 07/2007
2Thymidine KinaseIBA
11/2007 - 07/2007
29-(4-fluoro-3-hydroxymethylbutyl)guanineIBA
07/2007 - 02/2007
2Therapeutic UsesIBA
07/2007 - 02/2007
2ProdrugsIBA
02/2007 - 02/2003
1florbetapirIBA
01/2022
1PLX5622IBA
01/2022
1Amyloid (Amyloid Fibrils)IBA
01/2022
1pyrimidineIBA
01/2022
1Donepezil (Aricept)FDA LinkGeneric
01/2022
1AminesIBA
01/2022
1Amyloid beta-PeptidesIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Temozolomide (Temodar)FDA LinkGeneric
01/2021
1Monoclonal AntibodiesIBA
12/2020
1Cetuximab (Erbitux)FDA Link
12/2020
1ethyl tyrosine esterIBA
01/2020
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2020
1HLA-DR Antigens (HLA-DR)IBA
01/2020
1Biological ProductsIBA
10/2019
1Interleukin-4 (Interleukin 4)IBA
01/2018
1A-836339IBA
11/2017
11,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA
03/2017
1CB2 Cannabinoid ReceptorIBA
03/2017
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
03/2017
1Matrix Metalloproteinases (MMPs)IBA
01/2017
1erucylphospho- N,N,N- trimethylpropylammoniumIBA
12/2013
1Glial Fibrillary Acidic ProteinIBA
12/2013
1Indicators and Reagents (Reagents)IBA
07/2012
1GadoliniumIBA
07/2012
1LigandsIBA
05/2012
1alovudineIBA
06/2011
1CarcinogensIBA
03/2011
1CytokinesIBA
03/2011
1Bone Morphogenetic Protein 7IBA
03/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2011
1E2F1 Transcription FactorIBA
07/2008
1Phosphotransferases (Kinase)IBA
03/2008
1Firefly LuciferasesIBA
03/2008
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2008
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2008
1ThymidineIBA
01/2008
1Glycoproteins (Glycoprotein)IBA
11/2007
1fluorescent protein 583IBA
11/2007
1enhanced green fluorescent proteinIBA
07/2007

Therapy/Procedure

12Therapeutics
06/2022 - 02/2007
1Immunotherapy
01/2020
1Combined Modality Therapy
10/2019
1Lasers (Laser)
06/2011
1Molecular Targeted Therapy
03/2011
1Aftercare (After-Treatment)
01/2008